Herbert J. Kramer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Herbert J. Kramer has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Angela Bäcker
University of Bonn
3 shared publicationsJiri Heller
2 shared publicationsA. Bäcker
1 shared publication- Akira Nishiyama
Department of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan
1 shared publication - Alexandra Sporková
Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
1 shared publication Angela Baecker
Renal Section, Medical Policlinic, University of Bonn, Germany
1 shared publication
Latest Publications
- Open Access
- 20 May 2015
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 6, 66
Identification of Putative Natriuretic Hormones Isolated from Human Urine
This brief review describes some representative methodological approaches to the isolation of putative endogenous inhibitors of epithelial sodium transport - i. e. as ouabain-like factors (OLF) that inhibit the sodium transport enzyme Na-K-ATPase or inhibit the epithelial sodium channel (ENaC). Gel chromatography and reverse-phase (RP)-HPLC of lyophilized and reconstituted 24h-urine from salt-loaded healthy humans led to two active fractions, a hydrophilic OLF-1 and a lipophilic OLF-2 whose mass (Ms)-spectroscopic data indicate a Mr of 391 (1,2). Further identification was attempted by Ms-, IR-, UV- and 1H-NMR- spectroscopy. OLF-1 and OLF-2 may be closely related if not identical to (di)ascorbic acid or its salts such as vanadium (V)-Vv-diascorbate with Mr 403 (3) and VIV-diascorbate. OLF-1 and Vv-diascorbate are about 10-fold stronger inhibitors of Na-K-ATPase than OLF-2 and VIV-diascorbate, respectively. In conscious rats, i.v. infusion of OLF-1 and OLF-2 resulted in a strong natriuresis. In a similar study Cain et al. (4) isolated a sodium transport inhibitor from the urine of uremic patients by gel chromatography and RP-HPLC. In uremic rats a natriuretic response to the injection of the active material was found. Xanthurenic acid 8-O-ß-D-glucoside (Mr 368) and xanthurenic acid 8-O-sulfate (Mr 284) were identified as endogenous inhibitors of sodium transport acting, e.g. by ENaC blockade. No definite relation to blood pressure, body fluid volume or sodium balance has been reported for any of these above factors and further studies to identify the natriuretic and/or ouabain-like compound(s) or hormone(s) will be needed.
- 20 May 2015
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 6, 66
Open AccessIdentification of Putative Natriuretic Hormones Isolated from Human Urine
This brief review describes some representative methodological approaches to the isolation of putative endogenous inhibitors of epithelial sodium transport - i. e. as ouabain-like factors (OLF) that inhibit the sodium transport enzyme Na-K-ATPase or inhibit the epithelial sodium channel (ENaC). Gel chromatography and reverse-phase (RP)-HPLC of lyophilized and reconstituted 24h-urine from salt-loaded healthy humans led to two active fractions, a hydrophilic OLF-1 and a lipophilic OLF-2 whose mass (Ms)-spectroscopic data indicate a Mr of 391 (1,2). Further identification was attempted by Ms-, IR-, UV- and 1H-NMR- spectroscopy. OLF-1 and OLF-2 may be closely related if not identical to (di)ascorbic acid or its salts such as vanadium (V)-Vv-diascorbate with Mr 403 (3) and VIV-diascorbate. OLF-1 and Vv-diascorbate are about 10-fold stronger inhibitors of Na-K-ATPase than OLF-2 and VIV-diascorbate, respectively. In conscious rats, i.v. infusion of OLF-1 and OLF-2 resulted in a strong natriuresis. In a similar study Cain et al. (4) isolated a sodium transport inhibitor from the urine of uremic patients by gel chromatography and RP-HPLC. In uremic rats a natriuretic response to the injection of the active material was found. Xanthurenic acid 8-O-ß-D-glucoside (Mr 368) and xanthurenic acid 8-O-sulfate (Mr 284) were identified as endogenous inhibitors of sodium transport acting, e.g. by ENaC blockade. No definite relation to blood pressure, body fluid volume or sodium balance has been reported for any of these above factors and further studies to identify the natriuretic and/or ouabain-like compound(s) or hormone(s) will be needed.
- 1 November 2014
- Vol. 64 (5) , 906-7
A tribute to Hugh de Wardener.
- 1 March 2004
- Published by Elsevier in Kidney International
- Vol. 65 (3) , 982-989
Impaired response of the denervated kidney to endothelin receptor blockade in normotensive and spontaneously hypertensive rats
- 1 March 2004
- Published by Elsevier in Kidney International
- Vol. 65 (3) , 982-989
Impaired response of the denervated kidney to endothelin receptor blockade in normotensive and spontaneously hypertensive rats
- 2 February 2004
- Published by S. Karger AG in Kidney and Blood Pressure Research
- Vol. 27 (1) , 10-17
Relative Roles of Nitric Oxide, Prostanoids and Angiotensin II in the Regulation of Canine Glomerular Hemodynamics
Glomerular hemodynamics are controlled by a variety of physical, nervous and hormonal factors including the potent vasoconstrictors, angiotensin (ANG) II and endothelin-1 (ET-1), and the vasodilator prostanoids (prostaglandin = PG) and nitric oxide (NO). Since no micropuncture data on the canine kidney exist with respect to the relative roles of the endogenous vasoactive hormones/autacoids NO, PG and ANG II in modulating glomerular hemodynamics, in the present study using the micropuncture technique in anesthetized dogs on a normal salt intake, we investigated the relative effects of these hormones/autacoids by means of the L-arginine analog, Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME), a competitive NO synthase (NOS) inhibitor, the cyclooxygenase inhibitor indomethacin (INDO), and the AT1 receptor blocker EXP 3174. An intrarenal arterial (i.r.a.) bolus (within 5 min) of 2.5 mg of L-NAME led to a significant decrease in total renal blood flow (RBF) and single nephron glomerular blood flow (SNGBF) from 4.46 ± 0.51 to 3.52 ± 0.41 ml/min/g kidney weight and from 0.393 ± 0.041 to 0.341 ± 0.037 µl/min (p < 0.01), respectively, without a change in glomerular filtration rate (GFR). The increase in arteriolar resistance was more pronounced at the efferent (+31%) than at the afferent (+13%) arteriole, and Kf decreased from 4.5 ± 0.5 to 3.7 ± 0.4 nl/min/mm Hg (p < 0.01). INDO (5 mg/kg i.v. bolus followed by 0.17 mg/kg/min i.v.) had no effect on glomerular hemodynamics. EXP 3174 (30 µg/kg/min i.r.a.) increased RBF and SNGBF from 4.35 ± 0.45 to 4.99 ± 0.50 ml/min/g kidney weight and from 0.403 ± 0.028 to 0.478 ± 0.039 µl/min (p < 0.01), respectively, without an effect on GFR. It reduced the efferent arteriolar resistance by 25% as compared to 13% at the afferent arteriolar level. EXP 3174 increased Kf from 5.1 ± 0.4 to 8.1 ± 0.6 mm Hg (p < 0.01) in the presence of a decrease in effective filtration pressure from 13.2 ± 1.7 to 8.3 ± 1.0 mm Hg (p < 0.01). The glomerular hemodynamic effects of L-NAME were unaltered by pretreatment with INDO or EXP 3174, whereas its tubular effects were restored in the presence of EXP 3174. Thus, from these first micropuncture data in the anesthetized dog on a normal sodium intake we conclude that (1) acute intrarenal inhibition of NOS by L-NAME decreases RBF and SNGBF due to vasoconstriction of the afferent and, more pronounced, efferent arterioles. Since L-NAME simultaneously decreases Kf, GFR remains unaltered. (2) These renal hemodynamic effects of NOS inhibition were not mediated by prostanoids or intrarenal ANG II. Thus, the tonic activity of intrarenal NOS plays an important role in maintaining glomerular hemodynamics in the canine kidney.
- 2 February 2004
- Published by S. Karger AG in Kidney and Blood Pressure Research
- Vol. 27 (1) , 10-17
Relative Roles of Nitric Oxide, Prostanoids and Angiotensin II in the Regulation of Canine Glomerular Hemodynamics
Glomerular hemodynamics are controlled by a variety of physical, nervous and hormonal factors including the potent vasoconstrictors, angiotensin (ANG) II and endothelin-1 (ET-1), and the vasodilator prostanoids (prostaglandin = PG) and nitric oxide (NO). Since no micropuncture data on the canine kidney exist with respect to the relative roles of the endogenous vasoactive hormones/autacoids NO, PG and ANG II in modulating glomerular hemodynamics, in the present study using the micropuncture technique in anesthetized dogs on a normal salt intake, we investigated the relative effects of these hormones/autacoids by means of the L-arginine analog, Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME), a competitive NO synthase (NOS) inhibitor, the cyclooxygenase inhibitor indomethacin (INDO), and the AT1 receptor blocker EXP 3174. An intrarenal arterial (i.r.a.) bolus (within 5 min) of 2.5 mg of L-NAME led to a significant decrease in total renal blood flow (RBF) and single nephron glomerular blood flow (SNGBF) from 4.46 ± 0.51 to 3.52 ± 0.41 ml/min/g kidney weight and from 0.393 ± 0.041 to 0.341 ± 0.037 µl/min (p < 0.01), respectively, without a change in glomerular filtration rate (GFR). The increase in arteriolar resistance was more pronounced at the efferent (+31%) than at the afferent (+13%) arteriole, and Kf decreased from 4.5 ± 0.5 to 3.7 ± 0.4 nl/min/mm Hg (p < 0.01). INDO (5 mg/kg i.v. bolus followed by 0.17 mg/kg/min i.v.) had no effect on glomerular hemodynamics. EXP 3174 (30 µg/kg/min i.r.a.) increased RBF and SNGBF from 4.35 ± 0.45 to 4.99 ± 0.50 ml/min/g kidney weight and from 0.403 ± 0.028 to 0.478 ± 0.039 µl/min (p < 0.01), respectively, without an effect on GFR. It reduced the efferent arteriolar resistance by 25% as compared to 13% at the afferent arteriolar level. EXP 3174 increased Kf from 5.1 ± 0.4 to 8.1 ± 0.6 mm Hg (p < 0.01) in the presence of a decrease in effective filtration pressure from 13.2 ± 1.7 to 8.3 ± 1.0 mm Hg (p < 0.01). The glomerular hemodynamic effects of L-NAME were unaltered by pretreatment with INDO or EXP 3174, whereas its tubular effects were restored in the presence of EXP 3174. Thus, from these first micropuncture data in the anesthetized dog on a normal sodium intake we conclude that (1) acute intrarenal inhibition of NOS by L-NAME decreases RBF and SNGBF due to vasoconstriction of the afferent and, more pronounced, efferent arterioles. Since L-NAME simultaneously decreases Kf, GFR remains unaltered. (2) These renal hemodynamic effects of NOS inhibition were not mediated by prostanoids or intrarenal ANG II. Thus, the tonic activity of intrarenal NOS plays an important role in maintaining glomerular hemodynamics in the canine kidney.
- 11 April 2003
- Published by Elsevier in Biochemical Pharmacology
- Vol. 65 (10) , 1741-1746
Interaction of dimercaptosuccinic acid (DMSA) with angiotensin II on calcium mobilization in vascular smooth muscle cells.
- 11 April 2003
- Published by Elsevier in Biochemical Pharmacology
- Vol. 65 (10) , 1741-1746
Interaction of dimercaptosuccinic acid (DMSA) with angiotensin II on calcium mobilization in vascular smooth muscle cells.
- 1 July 2002
- Published by S. Karger AG in Kidney and Blood Pressure Research
- Vol. 25 (2) , 65-70
Hyperosmolality Induced by Betaine or Urea Stimulates Endothelin Synthesis by Differential Activation of ERK and p38 MAP Kinase in MDCK Cells
We have previously shown that cultured porcine inner medullary collecting duct cells produce endothelin (ET) which suppressed arginine vasopressin (AVP)-induced cyclic adenosine monophosphate (cAMP) generation in an autocrine/paracrine feedback-like fashion. Moreover, hyperosmolality, e.g. induced by sodium chloride and urea, stimulated ET synthesis. Since others showed that hyperosmolality also activates mitogen-activated protein (MAP) kinases and that p38 MAP kinase facilitates cellular influx of betaine to protect the cell from high extracellular solute (urea) concentrations, we were tempted to investigate a potential interaction of MAP kinases with ET production in cultured MDCK cells in response to extracellular hyperosmolality induced by betaine and urea, respectively. Increased extracellular tonicity (602 ± 8 vs. control of 323 ± 3 mosmol/kg H2O) induced by betaine stimulated ERK and, more strongly, p38 kinase activity at 0.5–2 h of incubation with a rise in ET-1 synthesis to 1,713 ± 68 vs. 378 ± 51 fmol/mg protein/24 h under control conditions (p < 0.01). The p38 MAP kinase inhibitor SB203580 suppressed the rise in betaine-induced ET-1 synthesis by 91% to 494 ± 38 fmol/mg protein/24 h, whereas the MEK/ERK inhibitor U0126 suppressed it moderately by 34%. Hypertonicity induced by urea moderately stimulated ERK but not p38 MAP kinase activity at 0.5–2 h and at 24–48 h and resulted in a modest rise in ET-1 synthesis to 681 ± 61 fmol/mg protein/24 h (p < 0.05) which was significantly suppressed by U0126 to 484 ± 16 fmol/mg protein/24 h. These results suggest that a functional interaction between the MAP kinases ERK and p38 MAP kinase and ET-1 synthesis is involved in betaine’s protection of MDCK cells in vitro which may represent an in vivo mechanism of protection from hyperosmotic stress induced by high extracellular solute concentrations.
- 1 July 2002
- Published by S. Karger AG in Kidney and Blood Pressure Research
- Vol. 25 (2) , 65-70
Hyperosmolality Induced by Betaine or Urea Stimulates Endothelin Synthesis by Differential Activation of ERK and p38 MAP Kinase in MDCK Cells
We have previously shown that cultured porcine inner medullary collecting duct cells produce endothelin (ET) which suppressed arginine vasopressin (AVP)-induced cyclic adenosine monophosphate (cAMP) generation in an autocrine/paracrine feedback-like fashion. Moreover, hyperosmolality, e.g. induced by sodium chloride and urea, stimulated ET synthesis. Since others showed that hyperosmolality also activates mitogen-activated protein (MAP) kinases and that p38 MAP kinase facilitates cellular influx of betaine to protect the cell from high extracellular solute (urea) concentrations, we were tempted to investigate a potential interaction of MAP kinases with ET production in cultured MDCK cells in response to extracellular hyperosmolality induced by betaine and urea, respectively. Increased extracellular tonicity (602 ± 8 vs. control of 323 ± 3 mosmol/kg H2O) induced by betaine stimulated ERK and, more strongly, p38 kinase activity at 0.5–2 h of incubation with a rise in ET-1 synthesis to 1,713 ± 68 vs. 378 ± 51 fmol/mg protein/24 h under control conditions (p < 0.01). The p38 MAP kinase inhibitor SB203580 suppressed the rise in betaine-induced ET-1 synthesis by 91% to 494 ± 38 fmol/mg protein/24 h, whereas the MEK/ERK inhibitor U0126 suppressed it moderately by 34%. Hypertonicity induced by urea moderately stimulated ERK but not p38 MAP kinase activity at 0.5–2 h and at 24–48 h and resulted in a modest rise in ET-1 synthesis to 681 ± 61 fmol/mg protein/24 h (p < 0.05) which was significantly suppressed by U0126 to 484 ± 16 fmol/mg protein/24 h. These results suggest that a functional interaction between the MAP kinases ERK and p38 MAP kinase and ET-1 synthesis is involved in betaine’s protection of MDCK cells in vitro which may represent an in vivo mechanism of protection from hyperosmotic stress induced by high extracellular solute concentrations.
- Open Access
- 1 April 2002
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 15 (4)
Enhanced JNK2 activity in the hypertrophic heart ventricle of Prague-Hypertensive Rat (PHR) is independent of circulating or tissue endothelin (ET)
Since MAP kinases may be involved in cardiac hypertrophy in spontaneously hypertensive rats and their activation may be due to stimulation by ET, we studied MAP kinases ERK, JNK and p38 and gene expression of preproET-1 mRNA and of ECE-1 mRNA in atrial and ventricular tissues of PHR and their normotensive controls (PNR). Systolic blood pressure was 208±15 in PHR vs 121±5 mm Hg in PNR (p<0.01). Total heart weight was 316±4 in PHR vs 247±4 mg/100 g b.w. in PNR (p<0.01). Left and right ventricular weights were 168±4 (p<0.01) and 57±2 (n.s.) in PHR vs 121±5 and 53±3 mg/100 g b.w. in PNR. Western blot analysis and immunocomplex activity assay showed no differences in ERK or p38 MAP kinase but significantly greater phosphorylation of JNK2 in PHR than in PNR with an increase in JNK2 activity in left ventricle to 6.4±1.5 in PHR vs 2.5±0.5 O.D. in PNR (each n=5; p<0.05). Plasma ET-1,2 was 10.5±1.9 in PHR vs 12.3±1.3 fmol/ml in PNR (each n=12). Using competitive PCR for quantitative analysis preproET-1 mRNA in heart ventricle was 1.20±0.27 in PHR vs 1.10±0.22 fmol/mg RNAtotal in PNR. In atrial tissue it was 2.68±0.49 in PHR vs 2.91±1.04 fmol/mg RNAtotal in PNR (each n=5; n.s.). We found between PHR and PNR no differences in ECE-1 mRNA expression in heart ventricle (0.68±0.15 vs 0.64±0.11 fmol/mg RNAtotal) or in heart atrium (1.10±0.51 vs 1.11±0.38 fmol/mg RNAtotal). Similarly, no differences in cardiac ET-1 protein content were noted. Thus, despite marked cardiac hypertrophy atrial and ventricular preproET-1 mRNA and ECE-1 mRNA expression was similar in PHR and PNR suggesting that the rise in JNK2 activity, probably contributing to ventricular hypertrophy in this model of spontaneous hypertension, was independent of the circulating or local tissue ET-1 system.
- 1 April 2002
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 15 (4)
Open AccessEnhanced JNK2 activity in the hypertrophic heart ventricle of Prague-Hypertensive Rat (PHR) is independent of circulating or tissue endothelin (ET)
Since MAP kinases may be involved in cardiac hypertrophy in spontaneously hypertensive rats and their activation may be due to stimulation by ET, we studied MAP kinases ERK, JNK and p38 and gene expression of preproET-1 mRNA and of ECE-1 mRNA in atrial and ventricular tissues of PHR and their normotensive controls (PNR). Systolic blood pressure was 208±15 in PHR vs 121±5 mm Hg in PNR (p<0.01). Total heart weight was 316±4 in PHR vs 247±4 mg/100 g b.w. in PNR (p<0.01). Left and right ventricular weights were 168±4 (p<0.01) and 57±2 (n.s.) in PHR vs 121±5 and 53±3 mg/100 g b.w. in PNR. Western blot analysis and immunocomplex activity assay showed no differences in ERK or p38 MAP kinase but significantly greater phosphorylation of JNK2 in PHR than in PNR with an increase in JNK2 activity in left ventricle to 6.4±1.5 in PHR vs 2.5±0.5 O.D. in PNR (each n=5; p<0.05). Plasma ET-1,2 was 10.5±1.9 in PHR vs 12.3±1.3 fmol/ml in PNR (each n=12). Using competitive PCR for quantitative analysis preproET-1 mRNA in heart ventricle was 1.20±0.27 in PHR vs 1.10±0.22 fmol/mg RNAtotal in PNR. In atrial tissue it was 2.68±0.49 in PHR vs 2.91±1.04 fmol/mg RNAtotal in PNR (each n=5; n.s.). We found between PHR and PNR no differences in ECE-1 mRNA expression in heart ventricle (0.68±0.15 vs 0.64±0.11 fmol/mg RNAtotal) or in heart atrium (1.10±0.51 vs 1.11±0.38 fmol/mg RNAtotal). Similarly, no differences in cardiac ET-1 protein content were noted. Thus, despite marked cardiac hypertrophy atrial and ventricular preproET-1 mRNA and ECE-1 mRNA expression was similar in PHR and PNR suggesting that the rise in JNK2 activity, probably contributing to ventricular hypertrophy in this model of spontaneous hypertension, was independent of the circulating or local tissue ET-1 system.
- 1 September 2001
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 38 (3) , 675-678
Renal hemodynamics in space
- 1 September 2001
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 38 (3) , 675-678
Renal hemodynamics in space